[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1252751A1 - Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix - Google Patents

Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix

Info

Publication number
HK1252751A1
HK1252751A1 HK18112076A HK18112076A HK1252751A1 HK 1252751 A1 HK1252751 A1 HK 1252751A1 HK 18112076 A HK18112076 A HK 18112076A HK 18112076 A HK18112076 A HK 18112076A HK 1252751 A1 HK1252751 A1 HK 1252751A1
Authority
HK
Hong Kong
Prior art keywords
acid esters
fumaric acid
pharmaceutical formulation
erosion matrix
erosion
Prior art date
Application number
HK18112076A
Other languages
Chinese (zh)
Inventor
Henrik Nilsson
Roland Rupp
Original Assignee
Fwp Ip Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fwp Ip Aps filed Critical Fwp Ip Aps
Publication of HK1252751A1 publication Critical patent/HK1252751A1/en

Links

HK18112076A 2009-01-09 2018-09-19 Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix HK1252751A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14361309P 2009-01-09 2009-01-09
DKPA200900034 2009-01-09

Publications (1)

Publication Number Publication Date
HK1252751A1 true HK1252751A1 (en) 2019-05-31

Family

ID=68652510

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18112076A HK1252751A1 (en) 2009-01-09 2018-09-19 Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix

Country Status (2)

Country Link
JP (1) JP7195354B2 (en)
HK (1) HK1252751A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10360869A1 (en) 2003-09-09 2005-04-07 Fumapharm Ag Use of fumaric acid derivatives for the treatment of heart failure, hyperkeratosis and asthma
ME02746B (en) 2004-10-08 2018-01-20 Forward Pharma As Controlled release pharmaceutical compositions comprising a fumaric acid ester
WO2007042034A1 (en) 2005-10-07 2007-04-19 Aditech Pharma Ab Controlled release pharmaceutical compositions comprising a fumaric acid ester

Also Published As

Publication number Publication date
JP7195354B2 (en) 2022-12-23
JP2021088591A (en) 2021-06-10

Similar Documents

Publication Publication Date Title
HK1180943A1 (en) Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
IL254839B (en) Derivatives of piperidine-4- and -2-carboxylic acids, perhydroazepine-4-carboxylic acid and (piperidin-4-yl)-acetic acid and pharmaceutical compositions comprising them
HK1169960A1 (en) Pharmaceutical formulation
IL248880A0 (en) Compositions comprising r-g-cysteic acid peptides and uses thereof
IL217912A (en) 5-amino-1- benzimidazole-pyrazole derivatives and pharmaceutical compositions comprising them
IL211683A0 (en) 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them
EP2419097A4 (en) Pharmaceutical compositions
IL188681A0 (en) Pharmaceutical compositions and methods utilizing a d-amino acid
ZA201106299B (en) Composition comprising caftaric acid and/or derivatives thereof
IL220097A (en) Pharmaceutical composition comprising oligopeptides
IL214887A0 (en) Fatty acid monoglyceride compositions
ZA201200079B (en) Pharmaceutical compositions and solid forms
EP2306998A4 (en) Pharmaceutical formulation
EP2558077A4 (en) Oral pharmaceutical composition comprising fenofibric acid and an alkalifying agent
IL208788A (en) Solid pharmaceutical formulation
IL213711A (en) Pharmaceutical formulation of nanonised fenofibrate
PL2298090T3 (en) Pharmaceutical or nutraceutical composition
HK1252751A1 (en) Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
EP2493979A4 (en) Compositions comprising polylactic acid and gum arabic
EP2542059A4 (en) Compositions comprising myristic acid and uses thereof
GB201013159D0 (en) Liquid compositions comprising vitamin d and uses thereof
IL214271A (en) Pharmaceutical composition comprising racemic aminopterin
GB0805292D0 (en) Pharmaceutical formulation